Ichiro Mori
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 2%
- Lymphatic System and Diseases
Papers in
-
- Angiogenesis and VEGF in Cancer 6
- Oncology 33
- Cancer-related Molecular Pathways 7
- Co-authors
- Kennichi Kakudo (74 shared papers)Misa Nakamura (56 shared papers)Yasushi Nakamura (46 shared papers)Amy M. Gehring (3 shared papers)Qifeng Yang (35 shared papers)Christopher T. Walsh (2 shared papers)Nobukazu Ishizaka (15 shared papers)Ryozo Nagai (15 shared papers)
- Journals
- Pathology International (18 papers)Modern Pathology (6 papers)Breast Cancer (4 papers)Breast Cancer Research and Treatment (4 papers)Biochemical and Biophysical Research Communications (4 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Ichiro Mori
201 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 154
- Endocrinology, Diabetes and Metabolism 627
- Oncology 1.0k
- Nephrology 269
- Cancer Research 450
- Molecular Biology 2.0k
Countries citing papers authored by Ichiro Mori
This map shows the geographic impact of Ichiro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Mori more than expected).
Fields of papers citing papers by Ichiro Mori
This network shows the impact of papers produced by Ichiro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Mori. The network helps show where Ichiro Mori may publish in the future.
Co-authors
The 25 scholars most cited alongside Ichiro Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 231 | |
| 2 | 1998 | 200 | |
| 3 | 2007 | 193 | |
| 4 | 1998 | 191 | |
| 5 | 2005 | 167 | |
| 6 | 1998 | 137 | |
| 7 | 2000 | 132 | |
| 8 | 2002 | 120 | |
| 9 | Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. | 2003 | 114 |
| 10 | 2009 | 111 | |
| 11 | 2019 | 105 | |
| 12 | 2001 | 99 | |
| 13 | Urokinase-type plasminogen activator system and breast cancer (Review). | 2005 | 98 |
| 14 | 2012 | 95 | |
| 15 | 2009 | 91 | |
| 16 | 2002 | 89 | |
| 17 | 1990 | 88 | |
| 18 | 2014 | 81 | |
| 19 | 1983 | 81 | |
| 20 | 2001 | 79 |
About Ichiro Mori
Ichiro Mori is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Genetics and Epidemiology, having authored 208 papers that have together received 5.9k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (15 papers), Adipose Tissue and Metabolism (8 papers), Parathyroid Disorders and Treatments (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Cancer-related Molecular Pathways (7 papers), AI in cancer detection (7 papers), Angiogenesis and VEGF in Cancer (6 papers) and Estrogen and related hormone effects (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (627 citations), Oncology (1.0k citations), Nephrology (269 citations), Cancer Research (450 citations) and Molecular Biology (2.0k citations). Ichiro Mori has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Kennichi Kakudo, Misa Nakamura, Yasushi Nakamura, Amy M. Gehring, Qifeng Yang, Christopher T. Walsh, Nobukazu Ishizaka, Ryozo Nagai, Minoru Ohno and Emiko Taniguchi. Their work appears in journals such as Pathology International, Modern Pathology, Breast Cancer, Breast Cancer Research and Treatment and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.